Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
HUTCHMED (China) Limited (GB:HCM)
LSE:HCM
RESEARCH TOOLSreports
HUTCHMED (China) Limited (HCM) Share Price & Analysis
2 Followers
HCM Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range173.60p - 338.00p
Previous Close290p
Volume53.97K
Average Volume (3M)83.30K
Market Cap
£2.53B
Enterprise Value1.90B
Total Cash (Recent Filing)$886.34M
Total Debt (Recent Filing)$86.13M
Price to Earnings (P/E)33.0
Beta1.62
Next Earnings
Jul 31, 2024EPS Estimate
-£0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.10
Shares Outstanding871,256,270
10 Day Avg. Volume95,328
30 Day Avg. Volume83,296
Standard Deviation0.13
R-Squared0.06
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)4.35
Price to Sales (P/S)509.78
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue25.04
Enterprise Value/Gross Profit4.18
Enterprise Value/Ebitda-23.57
Forecast
1Y Price Target
358.68pPrice Target Upside21.18% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
HUTCHMED (China) Limited News
Options Prices
Currently, No data available
---
Ownership Overview
1.25% Insiders
1.75% Mutual Funds
2.03% Other Institutional Investors
94.97% Public Companies and
Individual Investors
HCM FAQ
What was HUTCHMED (China) Limited’s price range in the past 12 months?
HUTCHMED (China) Limited lowest share price was 173.60p and its highest was 338.00p in the past 12 months.
What is HUTCHMED (China) Limited’s market cap?
Currently, no data Available
When is HUTCHMED (China) Limited’s upcoming earnings report date?
HUTCHMED (China) Limited’s upcoming earnings report date is Jul 31, 2024 which is in 96 days.
How were HUTCHMED (China) Limited’s earnings last quarter?
HUTCHMED (China) Limited released its earnings results on Feb 28, 2024. The company reported -0.112p earnings per share for the quarter, beating the consensus estimate of -0.173p by 0.061p.
Is HUTCHMED (China) Limited overvalued?
According to Wall Street analysts HUTCHMED (China) Limited’s price is currently Undervalued.
Does HUTCHMED (China) Limited pay dividends?
HUTCHMED (China) Limited does not currently pay dividends.
What is HUTCHMED (China) Limited’s EPS estimate?
HUTCHMED (China) Limited’s EPS estimate is -£0.04.
How many shares outstanding does HUTCHMED (China) Limited have?
HUTCHMED (China) Limited has 871,256,300 shares outstanding.
What happened to HUTCHMED (China) Limited’s price movement after its last earnings report?
HUTCHMED (China) Limited reported an EPS of -0.112p in its last earnings report, beating expectations of -0.173p. Following the earnings report the stock price went down -1.811%.
Which hedge fund is a major shareholder of HUTCHMED (China) Limited?
Currently, no hedge funds are holding shares in GB:HCM
---
HUTCHMED (China) Limited Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
358.68p (21.18% Upside)
358.68p (21.18% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
9.62%
12-Months-Change
Fundamentals
Return on Equity
15.29%
Trailing 12-Months
Asset Growth
17.31%
Trailing 12-Months
Company Description
HUTCHMED (China) Limited
Hutchison China Meditech is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Its reportable segments include the innovation platform and commercial platform. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The commercial platform includes a prescription drugs business and a consumer health business for over-the-counter drugs.
---
HCM Stock 12 Months Forecast
Average Price Target
358.68p
▲(21.18% Upside)
Technical Analysis
Best Analysts Covering HCM
1 Year
1 Year Success Rate
2/3 ratings generated profit
1 Year Average Return
+16.53%
reiterated a buy rating 2 months ago
Copying Jill Wu's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +16.53% per trade.
---